A phase 2 trial of Glucarpidase and Leucovorin in Osteosarcoma, run by BTG International Inc., recorded as terminated on the registry.
High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma is a phase 2 interventional study registered as NCT00634322 by BTG International Inc., with 7 participants recorded, started 2008-10 and due to reach its primary completion in 2009-03. Interventions recorded: glucarpidase, leucovorin. Conditions recorded: Osteosarcoma.
Linked to the drug Glucarpidase because the registry names it among its interventions and Osteosarcoma among its conditions. Registry record only: no result has been read by an editor.
Shares Glucarpidase, Leucovorin (folinic acid), Osteosarcoma and the tag pipeline.
Shares Glucarpidase and the tag pipeline.
Shares Osteosarcoma and the tag pipeline.
Shares Osteosarcoma and the tag pipeline.
Shares Leucovorin (folinic acid) and the tag pipeline.
Shares Leucovorin (folinic acid) and the tag pipeline.
Shares Osteosarcoma and the tag pipeline.
Shares Osteosarcoma and the tag pipeline.